Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03YUT
|
|||
| Former ID |
DNC013313
|
|||
| Drug Name |
2-chloro-1-(5-(pyridin-2-yl)oxazol-2-yl)ethanone
|
|||
| Synonyms |
2-chloro-1-(5-(pyridin-2-yl)oxazol-2-yl)ethanone; 945414-11-9; alpha-ketooxazole, 14f; SCHEMBL710273; CHEMBL229323; BDBM23135; MKVLXIACPLGLLP-UHFFFAOYSA-N; ZINC14980143; DA-40252; FT-0713758
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H7ClN2O2
|
|||
| Canonical SMILES |
C1=CC=NC(=C1)C2=CN=C(O2)C(=O)CCl
|
|||
| InChI |
1S/C10H7ClN2O2/c11-5-8(14)10-13-6-9(15-10)7-3-1-2-4-12-7/h1-4,6H,5H2
|
|||
| InChIKey |
MKVLXIACPLGLLP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase. J Med Chem. 2007 Jul 12;50(14):3359-68. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.